InvestorsHub Logo
Followers 1321
Posts 26908
Boards Moderated 6
Alias Born 12/10/2012

Re: None

Tuesday, 07/21/2020 8:21:49 AM

Tuesday, July 21, 2020 8:21:49 AM

Post# of 111
$WPDPF: Used to be $WCOTF..........

MBRX news today using WP1122........ POSITIVE FOR Covid19


Moleculin Biotech says second lab test found antiviral activity for potential COVID-19 treatment
7:46 AM ET 7/21/20 | Dow Jones
Related Quotes


4:00 PM ET 7/20/20
Symbol Last % Chg
MBRX
1.10 0.00%
Real time quote.



Shares of small-cap Moleculin Biotech Inc. soared 43% in premarket trade Tuesday, after the company said a second round of laboratory testing confirmed antiviral activity for WP1122, its candidate as a treatment for COVID-19. The lab involved was IIT Research Institute, an affiliate of the Illinois Institute of Technology, which conducted additional in vitro testing of the drug candidate. The testing involved a cell viability assay in the VERO E6 cell line infected with the coronavirus that causes COVID-19 and compared the therapeutic effects of 2-DG (the active ingredient in WP1122) alone with those of WP1122, a 2-DG prodrug.The result is very preliminary; based on feedback from the FDA, Moleculin expects it will need to show activity in a COVID-19 animal model to successfully submit a request for Investigational New Drug ("IND") status for WP1122. The company is testing other compounds in its portfolio as treatments for COVID-19. Shares have gained 20% in the year to date,

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

> Dow Jones Newswires

July 21, 2020 07:46 ET (11:46 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.



GO $WPDPF